Übersetzung für "Ad hoc meeting" in Deutsch

The PRAC considered the views expressed by experts during an ad-hoc meeting.

This was discussed with clinical experts within an ad hoc expert group meeting that confirmed a possible association but this has not yet been demonstrated.

The secretariat would present a brief working document at the next ad hoc group meeting.

An ad hoc meeting within the Council took place in May.

The PRAC also considered the views expressed by experts at an ad hoc expert group meeting.

We, too, have been a strong supporter of Palestinian state-building, so when the ad hoc Liaison Committee meeting was hosted by us on 13 April, I listened to the praise for the work of Salam Fayyad, for his remarkable achievements in governance, the rule of law and human rights, education, health and social protection - sufficient for a functioning government according to the World Bank.

The European Community and its Member States are committed to resolving this issue and can therefore support the organisation by the WIPO Secretariat of an ad hoc informal meeting in Geneva from 18 to 20 June 2003.

Then, as regards our Mediterranean partners, we shall be holding our customary ad hoc Euromed experts' meeting on terrorism, which will provide the opportunity to have wider discussions with our Mediterranean partners on a matter of vital interest in that region, and which will focus upon the implementation of priority areas of the Euro-Mediterranean Code of Conduct on Countering Terrorism.

There was an important meeting of the Quartet, of which I am a permanent member as part of the EU delegation, and an Ad Hoc Liaison Committee meeting of the major donors to the Palestinians, in preparation for a pledging conference that will probably take place at the end of December, after the international meeting that is now being prepared.

Having said that, we also know very clearly, and this was apparent from the second meeting we had, the Ad Hoc Liaison Committee meeting, that we cannot only have political negotiations.

Further to the request from the MAH, the CHMP convened an Ad-Hoc Expert meeting including experts on technology/formulation science, pharmacokinetics and clinical/medical practice in order to deliver answers on a consultative basis to specific questions in relation to the grounds for re-examination.

Based on the current evidence from the SIPPET study, as well as data from the individual clinical trials and observational studies included in the MAH responses, and the views expressed by the experts of the ad-hoc expert meeting, the PRAC agreed that the current evidence does not provide clear and consistent evidence of any statistically and clinically meaningful differences in inhibitor risk between rFVIII and pdFVIII products.

Having considered the abovementioned results from SIPPET, the published literature and all the information submitted by the MAHs, as well as the views expressed by experts expressed at the ad-hoc expert meeting, the PRAC concluded that: